Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Bioventus (BVS) over the last 5 years, with Q3 2025 value amounting to $0.05.

  • Bioventus' EPS (Weighted Average and Diluted) rose 16250.0% to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.16, marking a year-over-year increase of 12461.54%. This contributed to the annual value of -$0.52 for FY2024, which is 7911.65% up from last year.
  • According to the latest figures from Q3 2025, Bioventus' EPS (Weighted Average and Diluted) is $0.05, which was up 16250.0% from $0.11 recorded in Q2 2025.
  • Bioventus' 5-year EPS (Weighted Average and Diluted) high stood at $0.11 for Q2 2025, and its period low was -$2.24 during Q2 2023.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.08 (2024), whereas its average is -$0.3.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 9448276.46% in 2022, then soared by 16250.0% in 2025.
  • Over the past 5 years, Bioventus' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.0 in 2021, then plummeted by 94482.76% to -$0.52 in 2022, then skyrocketed by 82.69% to -$0.09 in 2023, then surged by 144.44% to $0.04 in 2024, then rose by 25.0% to $0.05 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.05 for Q3 2025, versus $0.11 for Q2 2025 and -$0.04 for Q1 2025.